Stocktoria

Ernexa Therapeutics Inc. ERNA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1991-08-29

Ernexa Therapeutics Inc. statistics & valuation

P / B3.4×
Return on capital-342.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
-247.10% 83.50% 2016201720182019202020212022202320242025
Operating margin (%)
-10.20% -6.60% 0.90% -8.90% -456.70% -31080.90% -2693.10% 2016201720182019202020212022202320242025
Return on equity (%)
-71.90% -19.50% -3.70% -21.00% -346.40% -480.50% -203.00% -970.40% -2618.40% -586.60% 2016201720182019202020212022202320242025
Shares outstanding
2.3M 2.5M 2.9M 2.9M 17.6M 2.6M 5.1M 5.4M 3.4M 6.3M 2016201720182019202020212022202320242025
Net debt ($)
$2.4M $1.7M $1.2M -$245000 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-17.50% -6.50% -1.70% -14.50% -192.60% -388.70% -110.30% -44.10% -845.30% -241.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-1.80% -0.80% 3.10% 13.20% -140.30% -30039.70% -2784.40% 2016201720182019202020212022202320242025
Debt / equity (×)
1.99× 0.93× 0.54× 0.07× 2016201720182019202020212022202320242025
EPS ($)
-$1.51 -$56.61 -$8.06 -$4.08 -$48.96 -$2.24 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin83.5%-247.1%
Operating margin-2693.1%-31080.9%-456.7%-8.9%0.9%-6.6%-10.2%
Net margin-7652.7%-31864.7%-457.4%-10.3%-1.1%-5.1%-13.1%
FCF margin-2784.4%-30039.7%-140.3%13.2%3.1%-0.8%-1.8%
Return on assets-241.4%-845.3%-44.1%-110.3%-388.7%-192.6%-14.5%-1.7%-6.5%-17.5%
Return on equity-586.6%-2618.4%-970.4%-203.0%-480.5%-346.4%-21.0%-3.7%-19.5%-71.9%
Debt / equity0.07×0.54×0.93×1.99×
Current ratio1.010.801.461.795.100.551.001.690.901.60

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.